(VIANEWS) – The NASDAQ opens in less than one hour and Arcturus Therapeutics‘s pre-market value is already 6.07% up.
The last session, NASDAQ Composite ended with Arcturus Therapeutics (ARCT) rising 1.56% to $42.98. NASDAQ Composite slid 0.64% to $14,486.20, after two successive sessions in a row of losses, on what was a somewhat down trend trading session.
Today’s last reported volume for Arcturus Therapeutics is 172688, 79.71% below its average volume of 851158.
Arcturus Therapeutics’s last close was $42.32, 67.37% below its 52-week high of $129.71.
Arcturus Therapeutics’s Sales
Arcturus Therapeutics’s sales growth is 625.3% for the ongoing quarter and 1814.2% for the next. The company’s growth estimates for the ongoing quarter is a negative 72.8% and positive 6.4% for the next.
Arcturus Therapeutics’s last day, last week, and last month’s current volatility was 1.96%, 3.65%, and 4.06%, respectively.
Arcturus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.70% (day), 6.45% (last week), and 6.24% (last month), respectively.
More news about Arcturus Therapeutics (ARCT).